MIDLAND, Mich., Oct. 18, 2017 -- Chemical Financial Corporation (NASDAQ:CHFC) announced that the Board of Directors of the Corporation declared a fourth quarter 2017 dividend on its common stock of $0.28 per share. The fourth quarter 2017 dividend will be payable on December 15, 2017, to shareholders of record on December 1, 2017. The ex-dividend date is November 30, 2017.
Chemical Financial Corporation is the largest banking company headquartered and operating branch offices in Michigan. Chemical Financial Corporation's common stock trades on The NASDAQ Stock Market under the symbol CHFC and is one of the issues comprising The NASDAQ Global Select Market and the S&P MidCap 400 Index. More information about the Corporation is available at Chemical Financial Corporation's website at www.chemicalbank.com under the Investor Information section.
For further information:
David T. Provost, CEO
Dennis L. Klaeser, CFO
989-839-5350


Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 



